These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8056046)

  • 21. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Natural killer (NK) activity in patients with HIV infection].
    Ortona L; Tamburrini E; Tumbarello M; Ventura G; Cauda R
    Boll Ist Sieroter Milan; 1988; 67(2):135-41. PubMed ID: 3228497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis toxin-sensitive GTP-binding proteins regulate activation-induced apoptotic cell death of human natural killer cells.
    Carracedo J; Ramírez R; Marchetti P; Pintado OC; Baixeras E; Martínez C; Kroemer G
    Eur J Immunol; 1995 Nov; 25(11):3094-9. PubMed ID: 7489748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of chemotherapy-induced and HIV-1-induced immunocompromise on NK and LAK activities using breast cancer and HIV-1 seropositive patient populations.
    Brenner BG; Gryllis C; Gornitsky M; Cupples W; Wainberg M
    Anticancer Res; 1991; 11(2):969-74. PubMed ID: 2064353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.
    Baron GC; Klimas NG; Fischl MA; Fletcher MA
    Diagn Immunol; 1985; 3(4):197-204. PubMed ID: 3866646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.
    Jones RA; Richards SJ; Patel D; Scott CS
    Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.
    Tran AC; Zhang D; Byrn R; Roberts MR
    J Immunol; 1995 Jul; 155(2):1000-9. PubMed ID: 7608531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
    Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
    Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity.
    Chong AS; Boussy IA; Jiang XL; Lamas M; Graf LH
    Cell Immunol; 1994 Aug; 157(1):92-105. PubMed ID: 7518755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
    Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
    J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
    Ljunggren K; Karlson A; Fenyö EM; Jondal M
    Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and function of CD7 molecule on human natural killer cells.
    Rabinowich H; Pricop L; Herberman RB; Whiteside TL
    J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression.
    Parsons MS; Tang CC; Jegaskanda S; Center RJ; Brooks AG; Stratov I; Kent SJ
    J Immunol; 2014 Jan; 192(1):308-15. PubMed ID: 24319263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.
    Mason PD; Sissons JG; Borysiewicz LK
    Immunology; 1993 Dec; 80(4):625-32. PubMed ID: 8307613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.